Non-[18F]FDG PET in clinical oncology

被引：92

作者：

Groves, Ashley M. ^{[1
]}

Win, Thida

Ben Haim, Simona

Ell, Peter J.

机构：

[1] UCL, Inst Nucl Med, London NW1 2BU, England

[2] Lister Hosp, Stevenage, Herts, England

来源：

LANCET ONCOLOGY | 2007年 / 8卷 / 09期

关键词：

D O I：

10.1016/S1470-2045(07)70274-7

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PET is an exquisitely sensitive molecular imaging technique using positron-emitting radioisotopes coupled to specific ligands. Many biological targets of great interest can be imaged with these radiolabelled ligands. This review describes the current status of non-18-fluorodeoxyglucose PET tracers that have a potential clinical effect in oncology. With the help of these tracers, knowledge is being acquired on the molecular characterisation of specific tumours, their biological signature, and postinterventional response. The potential role of these imaging probes for tumour detection and monitoring is progressively being recognised by clinical oncologists, biologists, and pharmacologists.

引用

收藏

页码：822 / 830

页数：9

相关论文

共 76 条

[41] Positron emission tomography with [18F]FDOPA and [18F]FDG in the imaging of small cell lung carcinoma:: preliminary results [J].

Jacob, T ;

Grahek, D ;

Younsi, N ;

Kerrou, K ;

Aide, N ;

Montravers, F ;

Balogova, S ;

Colombet, C ;

de Beco, V ;

Talbot, JN .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (09) :1266-1269

[42] Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas [J].

Jacobs, A ;

Voges, J ;

Reszka, R ;

Lercher, M ;

Gossmann, A ;

Kracht, L ;

Kaestle, C ;

Wagner, R ;

Wienhard, K ;

Heiss, WD .

LANCET, 2001, 358 (9283) :727-729

[43] 18F-fluorodeoxyglucose PET/CT in cancer imaging [J].

Kayani, Irfan ;

Groves, Ashley M. .

CLINICAL MEDICINE, 2006, 6 (03) :240-244

[44] Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development [J].

Kelloff, G ;

Hoffman, JM ;

Johnson, B ;

Scher, HI ;

Siegel, BA ;

Cheng, EY ;

Cheson, BD ;

O'Shaughnessy, J ;

Guyton, KZ ;

Mankoff, DA ;

Shankar, L ;

Larson, SM ;

Sigman, CC ;

Schilsky, RL ;

Sullivan, DC .

CLINICAL CANCER RESEARCH, 2005, 11 (08) :2785-2808

[45] Positron emission tomographic imaging with 11C-choline in differential diagnosis of head and neck tumors:: comparison with 18F-FDG PET [J].

Khan, N ;

Oriuchi, N ;

Ninomiya, H ;

Higuchi, T ;

Kamada, H ;

Endo, K .

ANNALS OF NUCLEAR MEDICINE, 2004, 18 (05) :409-417

[46] Quantitative micro positron emission tomography (PET) imaging for the in vivo determination of pancreatic islet graft survival [J].

Kim, Su-Jin ;

Doudet, Doris J. ;

Studenov, Andrei R. ;

Nian, Cuilan ;

Ruth, Thomas J. ;

Gambhir, Sanjiv Sam ;

McIntosh, Christopher H. S. .

NATURE MEDICINE, 2006, 12 (12) :1423-1428

[47]

Kobori D, 1999, CANCER-AM CANCER SOC, V86, P1638, DOI 10.1002/(SICI)1097-0142(19991101)86:9<1638::AID-CNCR4>3.0.CO

[48]

2-U

[49] Staging of carcinoid tumours with 18F-DOPA PET:: a prospective, diagnostic accuracy study [J].

Koopmans, Klaas P. ;

de Vries, Elisabeth G. E. ;

Kerna, Ido P. ;

Elsinga, Philip H. ;

Neels, Oliver C. ;

Sluiter, Wim J. ;

van der Horst-Schrivers, Anouk N. A. ;

Jager, Pieter L. .

LANCET ONCOLOGY, 2006, 7 (09) :728-734

[50] Experience with carbon-11 choline positron emission tomography in prostate carcinoma [J].

Kotzerke, J ;

Prang, J ;

Neumaier, B ;

Volkmer, B ;

Guhlmann, A ;

Kleischmidt, K ;

Hautmann, R ;

Reske, SN .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2000, 27 (09) :1415-1419

← 1 2 3 4 5 6 7 8 →